116 related articles for article (PubMed ID: 2015875)
41. Phase II multicenter study of human CD52 antibody in previously treated chronic lymphocytic leukemia. European Study Group of CAMPATH-1H Treatment in Chronic Lymphocytic Leukemia.
Osterborg A; Dyer MJ; Bunjes D; Pangalis GA; Bastion Y; Catovsky D; Mellstedt H
J Clin Oncol; 1997 Apr; 15(4):1567-74. PubMed ID: 9193354
[TBL] [Abstract][Full Text] [Related]
42. Splenic irradiation in the treatment of patients with chronic myelogenous leukemia or myelofibrosis with myeloid metaplasia. Results of daily and intermittent fractionation with and without concomitant hydroxyurea.
Wagner H; McKeough PG; Desforges J; Madoc-Jones H
Cancer; 1986 Sep; 58(6):1204-7. PubMed ID: 2427184
[TBL] [Abstract][Full Text] [Related]
43. Minimal Residual Disease Assessment Improves Prediction of Outcome in Patients With Chronic Lymphocytic Leukemia (CLL) Who Achieve Partial Response: Comprehensive Analysis of Two Phase III Studies of the German CLL Study Group.
Kovacs G; Robrecht S; Fink AM; Bahlo J; Cramer P; von Tresckow J; Maurer C; Langerbeins P; Fingerle-Rowson G; Ritgen M; Kneba M; Döhner H; Stilgenbauer S; Klapper W; Wendtner CM; Fischer K; Hallek M; Eichhorst B; Böttcher S
J Clin Oncol; 2016 Nov; 34(31):3758-3765. PubMed ID: 27573660
[TBL] [Abstract][Full Text] [Related]
44. Radiotherapy of splenomegaly : a palliative treatment option for a benign phenomenon in malignant diseases.
Kriz J; Micke O; Bruns F; Haverkamp U; Mücke R; Schäfer U; Seegenschmiedt H; Müller RP; Eich HT
Strahlenther Onkol; 2011 Apr; 187(4):221-4. PubMed ID: 21424304
[TBL] [Abstract][Full Text] [Related]
45. Radiation therapy for palliation of Eisenmenger's syndrome-associated painful splenomegaly.
Osorio JI; Watkins JM; Strange C; Jenrette JM
Radiat Med; 2008 Feb; 26(2):84-7. PubMed ID: 18301984
[TBL] [Abstract][Full Text] [Related]
46. Splenectomy for hypersplenism in chronic lymphocytic leukaemia and malignant non-Hodgkin's lymphoma.
Delpero JR; Houvenaeghel G; Gastaut JA; Orsoni P; Blache JL; Guerinel G; Carcassonne Y
Br J Surg; 1990 Apr; 77(4):443-9. PubMed ID: 2340397
[TBL] [Abstract][Full Text] [Related]
47. [Irradiation of the spleen in chronic leukemia].
Bünemann H
Strahlentherapie; 1974 Sep; 148(3):246-58. PubMed ID: 4531762
[No Abstract] [Full Text] [Related]
48. Consequences of two different doses to the lungs during a single dose of total body irradiation: results of a randomized study on 85 patients.
Girinsky T; Socie G; Ammarguellat H; Cosset JM; Briot E; Bridier A; Gluckman E
Int J Radiat Oncol Biol Phys; 1994 Nov; 30(4):821-4. PubMed ID: 7960983
[TBL] [Abstract][Full Text] [Related]
49. Radiotherapy for splenomegaly.
Mod H; Prasiko G; Jha AK; Chaurasia PP; Srivastava R
JNMA J Nepal Med Assoc; 2005; 44(159):97-9. PubMed ID: 16554863
[TBL] [Abstract][Full Text] [Related]
50. Splenectomy in mantle cell lymphoma with leukaemia: a comparison with chronic lymphocytic leukaemia.
Ruchlemer R; Wotherspoon AC; Thompson JN; Swansbury JG; Matutes E; Catovsky D
Br J Haematol; 2002 Sep; 118(4):952-8. PubMed ID: 12199772
[TBL] [Abstract][Full Text] [Related]
51. Splenectomy during chronic lymphocytic leukemia.
Pegourie B; Sotto JJ; Hollard D; Michallet M; Sotto MF
Cancer; 1987 May; 59(9):1626-30. PubMed ID: 3828962
[TBL] [Abstract][Full Text] [Related]
52. [Symptomatic irradiation therapy of the spleen in advanced osteomyelosclerosis].
Slanina J; Vondraczek A; Wannenmacher M
Dtsch Med Wochenschr; 1986 Jul; 111(30):1144-50. PubMed ID: 2426078
[TBL] [Abstract][Full Text] [Related]
53. The value of splenectomy in chronic lymphocytic leukemia.
Delpero JR; Gastaut JA; Letreut YP; Caamano A; Mathieu-Tubiana N; Maraninchi D; Simon-Lejeune C; Mascret B; Blanc AP; Sebahoun G
Cancer; 1987 Jan; 59(2):340-5. PubMed ID: 3802020
[TBL] [Abstract][Full Text] [Related]
54. Therapy program for patients with advanced stages of chronic lymphocytic leukemia. Chlorambucil, splenectomy, and total lymph node irradiation.
Pegourie-Bandelier B; Sotto JJ; Hollard D; Bolla M; Sarrazin R
Cancer; 1995 Jun; 75(12):2853-61. PubMed ID: 7773934
[TBL] [Abstract][Full Text] [Related]
55. Treatment of symptomatic splenomegaly with low doses of radiotherapy: Retrospective analysis and review of the literature.
de la Pinta C; Fernández Lizarbe E; Montero Luis Á; Domínguez Rullán JA; Sancho García S
Tech Innov Patient Support Radiat Oncol; 2017; 3-4():23-29. PubMed ID: 32095563
[TBL] [Abstract][Full Text] [Related]
56. Adaptive splenic radiotherapy for symptomatic splenomegaly management in myeloproliferative disorders.
Sager O; Beyzadeoglu M; Dincoglan F; Demiral S; Uysal B; Gamsiz H; Akin M; Gundem E; Dirican B
Tumori; 2015; 101(1):84-90. PubMed ID: 25702680
[TBL] [Abstract][Full Text] [Related]
57. Eradication of minimal residual disease in B-cell chronic lymphocytic leukemia after alemtuzumab therapy is associated with prolonged survival.
Moreton P; Kennedy B; Lucas G; Leach M; Rassam SM; Haynes A; Tighe J; Oscier D; Fegan C; Rawstron A; Hillmen P
J Clin Oncol; 2005 May; 23(13):2971-9. PubMed ID: 15738539
[TBL] [Abstract][Full Text] [Related]
58. Treatment of prolymphocytic leukemia.
Hollister D; Coleman M
Cancer; 1982 Nov; 50(9):1687-9. PubMed ID: 6956431
[TBL] [Abstract][Full Text] [Related]
59. Watch and Wait in Lebanese Chronic Lymphocytic Leukemia Patients: How Relevant is it?
Lutfallah AA; Kourie HR; Eid R; Farhat F; Ghosn M; Kattan J
Asian Pac J Cancer Prev; 2016; 17(1):215-7. PubMed ID: 26838212
[TBL] [Abstract][Full Text] [Related]
60. Low-dose involved-field radiation in the treatment of non-hodgkin lymphoma: predictors of response and treatment failure.
Russo AL; Chen YH; Martin NE; Vinjamoori A; Luthy SK; Freedman A; Michaelson EM; Silver B; Mauch PM; Ng AK
Int J Radiat Oncol Biol Phys; 2013 May; 86(1):121-7. PubMed ID: 23414765
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
